LYKA LABS LTD. - 500259 - Receipt Of Product Permission From Central Drugs Standard Control Organization Of India For Tofacitinib Ointment 2% W/W.
Pursuant to Reg 30 of the SEBI (LODR) Regulations 2015, we would like to informed you that, the Company has received product permission from Central Drugs Standards Control Organisation of India to manufacture and market Tofacitinib Ointment 2% w/w. LYKA LABS LTD. - 500259 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Reg 39 (3) of the SEBI (LODR) Regulations 2015, the Company has issued duplicate share certificate (details as attached) LYKA LABS LTD. - 500259 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation for Loss of Share Certificates under Reg 39 (3) of the SEBI (LODR) Regulations 2015. LYKA LABS LTD. - 500259 - Closure of Trading Window
Pursuant to the SEBI (PIT) Regulations 2015, the trading window for dealing in the securities of the Company shall remained closed w.e.f. 1st October 2023 till 48 hours after the announcement of unaudited financial results of the Company for the quarter and half year ended 30th September 2023. LYKA LABS LTD. - 500259 - Announcement under Regulation 30 (LODR)-Change in Directorate
Pursuant to Regulation 30 of the SEBI(LODR)Regulations 2015, the Company informed about the cessation of Mr. Sandeep Parikh, on completion of his term as an Independent Director of the Company. LYKA LABS LTD. - 500259 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015;the Company has issued duplicate shares certificates. LYKA LABS LTD. - 500259 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Lyka Generics Ltd & PACs LYKA LABS LTD. - 500259 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Enai Trading & Investment Pvt Ltd & PACs LYKA LABS LTD. - 500259 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nehal N Gandhi & PACs LYKA LABS LTD. - 500259 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kunal Gandhi & PACs